Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMLODIPINE\ATORVASTATIN: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

59.0%
Female
41.0%
Male

Age Information

The average age of patients reporting adverse events with AMLODIPINE\ATORVASTATIN is 69.5 years.

Geographic Distribution

The majority of adverse event reports for AMLODIPINE\ATORVASTATIN originate from US.

Report Summary & Outcomes

636
Total Reports
636
As Primary/Secondary Suspect
44
Deaths Reported
133
Hospitalizations
10
Life-Threatening
15
Disabilities

Reporting Timeline

First adverse event report: 1988. Most recent report: 20250506. View full timeline →

More About AMLODIPINE\ATORVASTATIN

AMLODIPINE\ATORVASTATIN Full Profile Reports by Year Drug Interactions